carbohydrates

229 проекта

HEИндивидуална стипендия2025–2027Германия

REALIGN · Assessing the efficacy and acceptability of timed exercise to improve glucose variability and metabolic flexibility in adults with prediabetes

HEИндивидуална стипендия2025–2026Швеция

BISCUITS · Multi-Omics-based BIomarker Signatures of dietary Carbohydrates qUalITy and risk of chronic diseaseS.

2 партньори · 2 държави

HEИндивидуална стипендия2025–2027Дания

FROM · Formose Reactions on Microdroplets (FROM)

HEИндивидуална стипендия2025–2026Белгия

INTERLAYER · Building self-supporting all-liquid hierarchical constructs using polysaccharide nanoparticles-stabilized interfaces

HEИндивидуална стипендия2025–2026Белгия

Waste2Ethanol · Understanding yeasts and lactic acid bacteria interactions to develop a mixed culture bioprocess for the production of ethanol from food waste

2 партньори · 2 държави

HEИндивидуална стипендия2024–2026Испания

SPIRAL · Structural exploration of GD3 ganglioside-COVID spike Protein Interaction and siglec-7 Role in inhibition of virAL infection

HEИндивидуална стипендия2024–2026Швеция

EBOVmembrinteract · Molecular mechanisms behind filovirus entry and egress: the role of viral glycoprotein glycosylation

HEИндивидуална стипендия2024–2026Испания

BIOCOMAT · Enhancing Bioavailability of Beneficial Polyphenolic Compounds in Food via Advanced Materials Engineering

2 партньори

HEИндивидуална стипендия2024–2027Дания

HASPS · Hide and Seek: Exploring PFAS Accumulated in Urban Sludge

2 партньори · 2 държави

HEИндивидуална стипендия2024–2026Белгия

SugarPain · Unravelling interactions between fermentable carbohydrates and the gut microbiota in patients with IBS

HEИндивидуална стипендия2024–2026Португалия

COxEnzymes - AGs · New Carbohydrate Oxidising Enzymes prepared by directed evolution and their application in synthesis of AminoGlycoside derivatives with antibiotic potential and rare sugars.

HEИндивидуална стипендия2024–2026Швеция

GlycoDiet · Disruption of Mucin Glycosylation and Mucus Barrier Function in Response to a Western-Style Diet

HEИндивидуална стипендия2024–2026Германия

The disease facTOR · The emerging role of TARGET OF RAPAMYCIN in regulating the shade-induced pathogen susceptibility in plants

HEДокторантска мрежа2024–2028Италия

ENSCC · European Network on the Supramolecular Chemistry of Carbohydrates

13 партньори · 7 държави

HEИндивидуална стипендия2024–2026Испания

COFPOR-4-fuels · Fuel forming electrocatalysis: Devising multifunctional covalent organic frameworks with vinylenic linkage for electrocatalytic CO2 reduction and water oxidation

HEИндивидуална стипендия2024–2025Швеция

ECHOS · Exploring aCtive edible materials based on pHenolic-biocOnjugates from agro-industrial by-products for Sustainable and healthy future food packaging

4 партньори · 3 държави

HEИндивидуална стипендия2024–2026Дания

RHAPPLE · Novel biotechnological route for the isolation and investigation of rhamnogalacturonan-I from apple side-streams as model systems

HEИндивидуална стипендия2024–2026Ирландия

DesiRTA · Localize and Controlled co-delivery of AuNPs conjugated siRNA by Cationic Shear-thinning Gel Matrix for Treatment of Arthritis (DesiRTA)

2 партньори · 2 държави

HEИндивидуална стипендия2023–2025Норвегия

GlycoMap · Integrated Glycomics for Cancer Precision Medicine

2 партньори · 2 държави

HEДокторантска мрежа2023–2027Италия

GlyCanDrug · A training network on the design of precision therapeutics that target key glycan motifs implicated in cancer

21 партньори · 11 държави

HEИндивидуална стипендия2023–2025Дания

GlycoEggshell · Glycoprotein (Glyco+protein) of the biomineralized eggshell in birds

2 партньори · 2 държави

HEОбмен на изследователи2023–2026Германия

HEPINIB · Heparanase inhibition as a multifunctional targeting approach in cancer

14 партньори · 7 държави

HEДокторантска мрежа2023–2026Италия

GlycoNoVi · Understanding the Role of Glycans in Human Norovirus Infection: a Key to Unlock New Therapies

15 партньори · 8 държави

HEИндивидуална стипендия2022–2024Нидерландия

glyCoVdrugs · Inverting α-glucosidase inhibitors as potential drugs for SARS-CoV-2